Document is current
Any future updates will be listed below
-
Authors
Schouw, H. M. https://orcid.org/0000-0002-8996-4353
Melis, J
Lutterop, J. W.
Boersma, H. H.
Noltes, M. E.
van der Hilst, C. S.
Bonnema, M. I.
Appelman, A. P. A.
Zandee, W. T.
Kruijff, S.
Vermeulen, K. M.
Brouwers, A. H.
- License Information
-
More Information
Article History
Received: 8 August 2025
Accepted: 24 December 2025
First Online: 9 February 2026
Declarations
:
: Study was approved by the Central Ethics Review Board for non-WMO studies (CTc UMCG), (research registry number 11168)
: Written informed consent was obtained from all patients that were included in this study.
: No competing interests to report. The CHEERS 2022 checklist (as presented in Table 1 of Husereau et al., PharmacoEconomics , 2022) was used as a framework to guide the reporting of this health economic evaluation. While minor deviations from the checklist were made in certain areas (e.g., the title), the majority of items were addressed in accordance with the recommended standards.
